Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.

Por Coutlée, F, Provencher, D, Voyer, H
Publicado em 1995

Absence of human papillomavirus sequences in ovarian pathologies.

Por Trottier, A M, Provencher, D, Mes-Masson, A M, Vauclair, R, Coutlée, F
Publicado em 1995

Multimodality breast cancer screening in women with a familial or genetic predisposition

Por Trop, I., Lalonde, L., Mayrand, M.H., David, J., Larouche, N., Provencher, D.
Publicado em 2010

Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma

Por Chene, G., Ouellet, V., Rahimi, K., Barres, V., Meunier, L., De Ladurantaye, M., Provencher, D., Mes-Masson, A. M.
Publicado no Biomed Res Int (2015)

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens

Por Krasner, C N, McMeekin, D S, Chan, S, Braly, P S, Renshaw, F G, Kaye, S, Provencher, D M, Campos, S, Gore, M E
Publicado em 2007

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

Por Wojnarowicz, P, Gambaro, K, de Ladurantaye, M, Quinn, M C J, Provencher, D, Mes-Masson, A-M, Tonin, P N
Publicado em 2012

Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer

Por Le Page, C, Ouellet, V, Madore, J, Ren, F, Hudson, T J, Tonin, P N, Provencher, D M, Mes-Masson, A-M
Publicado em 2006

Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec

Por Spence, A.R., Alobaid, A., Drouin, P., Goggin, P., Gilbert, L., Provencher, D., Tousignant, P., Hanley, J.A., Franco, E.L.
Publicado no Curr Oncol (2014)

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Por Tonin, P N, Mes-Masson, A M, Futreal, P A, Morgan, K, Mahon, M, Foulkes, W D, Cole, D E, Provencher, D, Ghadirian, P, Narod, S A
Publicado em 1998

Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective

Por Oza, A.M., Castonguay, V., Tsoref, D., Diaz–Padilla, I., Karakasis, K., Mackay, H., Welch, S., Weberpals, J., Hoskins, P., Plante, M., Provencher, D., Tonkin, K., Covens, A., Ghatage, P., Gregoire, J., Hirte, H., Miller, D., Rosen, B., Maroun, J., Buyse, M., Coens, C., Brady, M.F., Stuart, G.C.E.
Publicado em 2011

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

Por Casilli, F, Tournier, I, Sinilnikova, O M, Coulet, F, Soubrier, F, Houdayer, C, Hardouin, A, Berthet, P, Sobol, H, Bourdon, V, Muller, D, Fricker, J P, Capoulade‐Metay, C, Chompret, A, Nogues, C, Mazoyer, S, Chappuis, P, Maillet, P, Philippe, C, Lortholary, A, Gesta, P, Bézieau, S, Toulas, C, Gladieff, L, Maugard, C M, Provencher, D M, Dugast, C, Delvincourt, C, Nguyen, T D, Faivre, L, Bonadona, V, Frébourg, T, Lidereau, R, Stoppa‐Lyonnet, D, Tosi, M
Publicado em 2006